{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:55:18Z","timestamp":1781790918872,"version":"3.54.5"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,13]],"date-time":"2027-01-13T00:00:00Z","timestamp":1799798400000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.virol.2026.110788","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T07:54:31Z","timestamp":1767945271000},"page":"110788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Selective reactivation of latent HIV using CyclinT1-Tat-containing virus-like particles"],"prefix":"10.1016","volume":"616","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0269-3325","authenticated-orcid":false,"given":"Thomas K.","family":"Lavin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline O.","family":"Tabler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najwa","family":"Alhusaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4218-5870","authenticated-orcid":false,"given":"John C.","family":"Tilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.virol.2026.110788_bib1","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1128\/JVI.74.12.5395-5402.2000","article-title":"Efficient particle production by minimal gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 Capsid-p2 and a late assembly domain","volume":"74","author":"Accola","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.110788_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12985-025-02744-4","article-title":"Inhibition of ALKBH5 demethylase of m6A pathway potentiates HIV-1 reactivation from latency","volume":"22","author":"Ali","year":"2025","journal-title":"Virol. J."},{"issue":"10","key":"10.1016\/j.virol.2026.110788_bib3","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/s41587-023-02078-y","article-title":"Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo","volume":"42","author":"An","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.virol.2026.110788_bib4","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/QAD.0b013e32835535f5","article-title":"Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-Treated patients","volume":"26","author":"Bouchat","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2026.110788_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/srep39032","article-title":"In vitro effects of the small-molecule protein kinase C agonists on HIV latency reactivation","volume":"6","author":"Brogdon","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2026.110788_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10844","article-title":"Elimination of HIV-1-infected cells by broadly neutralizing antibodies","volume":"7","author":"Bruel","year":"2016","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.virol.2026.110788_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168027","article-title":"Euphorbia kansui reactivates latent HIV","volume":"11","author":"Cary","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.virol.2026.110788_bib9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nbt745","article-title":"A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes","volume":"20","author":"Cavrois","year":"2002","journal-title":"Nat. Biotechnol."},{"issue":"11","key":"10.1016\/j.virol.2026.110788_bib10","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nbt745","article-title":"A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes","volume":"20","author":"Cavrois","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virol.2026.110788_bib11","first-page":"333","article-title":"Fluorescence resonance energy transfer-based HIV-1 virion fusion assay","volume":"263","author":"Cavrois","year":"2004","journal-title":"Meth. Mol. Biol. Clifton NJ"},{"issue":"16","key":"10.1016\/j.virol.2026.110788_bib12","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.1212","article-title":"HIV-1 fusion assay","volume":"4","author":"Cavrois","year":"2014","journal-title":"Bio-Protoc."},{"key":"10.1016\/j.virol.2026.110788_bib13","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1038\/s41467-025-60001-2","article-title":"Efficient mRNA delivery to resting T cells to reverse HIV latency","volume":"16","author":"Cevaal","year":"2025","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.virol.2026.110788_bib14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-020-0274-9","article-title":"CD8+ T cells in HIV control, cure and prevention","volume":"20","author":"Collins","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.virol.2026.110788_bib15","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.molcel.2017.07.025","article-title":"The short isoform of BRD4 promotes HIV-1 latency by engaging repressive SWI\/SNF chromatin-remodeling complexes","volume":"67","author":"Conrad","year":"2017","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.virol.2026.110788_bib16","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.3390\/v15122435","article-title":"Breaking the silence: regulation of HIV transcription and latency on the road to a cure","volume":"15","author":"Duggan","year":"2023","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.virol.2026.110788_bib17","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1128\/JVI.72.2.1666-1670.1998","article-title":"Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line","volume":"72","author":"Emiliani","year":"1998","journal-title":"J. Virol."},{"issue":"7327","key":"10.1016\/j.virol.2026.110788_bib18","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.virol.2026.110788_bib19","doi-asserted-by":"crossref","first-page":"12934","DOI":"10.1128\/JVI.76.24.12934-12939.2002","article-title":"A minimal chimera of human cyclin T1 and tat binds TAR and activates human immunodeficiency virus transcription in murine cells","volume":"76","author":"Fujinaga","year":"2002","journal-title":"J. Virol."},{"issue":"22","key":"10.1016\/j.virol.2026.110788_bib20","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1101\/gad.12.22.3512","article-title":"The interaction between HIV-1 tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein","volume":"12","author":"Garber","year":"1998","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.virol.2026.110788_bib21","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/j.cell.2025.03.015","article-title":"Engineered nucleocytosolic vehicles for loading of programmable editors","volume":"188","author":"Geilenkeuser","year":"2025","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.virol.2026.110788_bib22","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1128\/JVI.01847-06","article-title":"CD8 T-Cell recognition of multiple epitopes within specific gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-Seropositive patients","volume":"81","author":"Geldmacher","year":"2007","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virol.2026.110788_bib23","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/mt.2016.117","article-title":"Development of an attenuated tat protein as a highly-effective agent to specifically activate HIV-1 latency","volume":"24","author":"Geng","year":"2016","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.virol.2026.110788_bib24","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41587-023-02085-z","article-title":"In vivo human T cell engineering with enveloped delivery vehicles","volume":"42","author":"Hamilton","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.virol.2026.110788_bib25","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1080\/21645515.2018.1489949","article-title":"Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV able to recognize virus-infected cells in macaques","volume":"14","author":"Hu","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"issue":"10","key":"10.1016\/j.virol.2026.110788_bib26","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/nm1639","article-title":"Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes","volume":"13","author":"Huang","year":"2007","journal-title":"Nat. Med."},{"issue":"22","key":"10.1016\/j.virol.2026.110788_bib27","doi-asserted-by":"crossref","first-page":"12596","DOI":"10.1128\/JVI.01088-07","article-title":"Sequence of human immunodeficiency virus type 1 (HIV-1) gag localization and oligomerization monitored with live confocal imaging of a replication-competent, fluorescently tagged HIV-1","volume":"81","author":"H\u00fcbner","year":"2007","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2026.110788_bib28","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/path.2768","article-title":"Tat acetylation regulates its actions on microtubule dynamics and apoptosis in T lymphocytes","volume":"223","author":"Huo","year":"2011","journal-title":"J. Pathol."},{"issue":"11","key":"10.1016\/j.virol.2026.110788_bib29","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1128\/MCB.01013-13","article-title":"Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat","volume":"34","author":"Jadlowsky","year":"2014","journal-title":"Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.virol.2026.110788_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005066","article-title":"Synergistic reactivation of latent HIV expression by Ingenol-3-Angelate, PEP005, targeted NF-kB signaling in combination with JQ1 induced p-TEFb activation","volume":"11","author":"Jiang","year":"2015","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.virol.2026.110788_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004287","article-title":"Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes","volume":"10","author":"Jones","year":"2014","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.virol.2026.110788_bib32","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/emboj\/cdg188","article-title":"HIV reproducibly establishes a latent infection after acute infection of T cells in vitro","volume":"22","author":"Jordan","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2026.110788_bib33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12977-018-0421-6","article-title":"HIV latency reversing agents act through tat post translational modifications","volume":"15","author":"Khoury","year":"2018","journal-title":"Retrovirology"},{"issue":"7","key":"10.1016\/j.virol.2026.110788_bib34","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/jvi.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome","volume":"68","author":"Koup","year":"1994","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.virol.2026.110788_bib35","doi-asserted-by":"crossref","first-page":"9214","DOI":"10.1128\/JVI.74.19.9214-9221.2000","article-title":"Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes","volume":"74","author":"Kutsch","year":"2000","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2026.110788_bib36","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1172\/JCI80142","article-title":"Ex vivo analysis identifies effective HIV-1 latency\u2013reversing drug combinations","volume":"125","author":"Laird","year":"2015","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.virol.2026.110788_bib37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41565-024-01851-7","article-title":"Customizable virus-like particles deliver CRISPR-Cas9 ribonucleoprotein for effective ocular neovascular and Huntington's disease gene therapy","volume":"20","author":"Ling","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"11","key":"10.1016\/j.virol.2026.110788_bib38","doi-asserted-by":"crossref","first-page":"7626","DOI":"10.1074\/jbc.M112.408294","article-title":"The presence of HIV-1 tat protein second exon delays fas protein-mediated apoptosis in CD4+ T lymphocytes","volume":"288","author":"L\u00f3pez-Huertas","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.virol.2026.110788_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41467-018-07845-z","article-title":"Genome editing in primary cells and in vivo using viral-derived nanoblades loaded with Cas9-sgRNA ribonucleoproteins","volume":"10","author":"Mangeot","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.virol.2026.110788_bib40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.it.2022.11.003","article-title":"New insights into transcription elongation control of HIV-1 latency and rebound","volume":"44","author":"Mbonye","year":"2023","journal-title":"Trends Immunol."},{"issue":"13","key":"10.1016\/j.virol.2026.110788_bib41","doi-asserted-by":"crossref","first-page":"7089","DOI":"10.1128\/JVI.78.13.7089-7096.2004","article-title":"Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo","volume":"78","author":"Mulky","year":"2004","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virol.2026.110788_bib42","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1007\/s12035-024-04173-w","article-title":"Transactivator of transcription (Tat)-Induced neuroinflammation as a key pathway in neuronal dysfunction: a scoping review","volume":"61","author":"Muvenda","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.virol.2026.110788_bib43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12951-021-00806-7","article-title":"Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers","volume":"19","author":"Nooraei","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.virol.2026.110788_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032845","article-title":"Placement of leucine zipper motifs at the carboxyl terminus of HIV-1 protease significantly reduces virion production","volume":"7","author":"Pan","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.virol.2026.110788_bib45","doi-asserted-by":"crossref","first-page":"8397","DOI":"10.1038\/s41467-023-44020-5","article-title":"Potent latency reversal by tat RNA-containing nanoparticle enables multi-omic analysis of the HIV-1 reservoir","volume":"14","author":"Pardons","year":"2023","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.virol.2026.110788_bib46","doi-asserted-by":"crossref","first-page":"12291","DOI":"10.1128\/JVI.01383-08","article-title":"Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency","volume":"82","author":"Pearson","year":"2008","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.virol.2026.110788_bib47","doi-asserted-by":"crossref","first-page":"12291","DOI":"10.1128\/JVI.01383-08","article-title":"Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency","volume":"82","author":"Pearson","year":"2008","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virol.2026.110788_bib48","doi-asserted-by":"crossref","first-page":"e00201","DOI":"10.1128\/aac.00201-24","article-title":"Nanoparticle delivery of tat synergizes with classical latency reversal agents to express HIV antigen targets","volume":"68","author":"Raines","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.virol.2026.110788_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005013","article-title":"Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection","volume":"4","author":"Ramduth","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2026.110788_bib50","doi-asserted-by":"crossref","unstructured":"Rao VR, Rodriguez M, Byrareddy SN, Ranga U, Prasad VR. Neurovirulent and non-neurovirulent strains of HIV-1 and their tat proteins induce differential cytokine-chemokine profiles. Neuroimmune Pharmacol Ther. 4(1):39\u201347.","DOI":"10.1515\/nipt-2024-0020"},{"issue":"6","key":"10.1016\/j.virol.2026.110788_bib51","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/mt.2014.29","article-title":"An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription","volume":"22","author":"Saayman","year":"2014","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.virol.2026.110788_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000263","article-title":"miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1","volume":"5","author":"Sung","year":"2009","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.virol.2026.110788_bib53","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1089\/aid.2016.0168","article-title":"Conserved HIV-1 gag p24 epitopes elicit cellular immune responses that impact disease outcome","volume":"33","author":"Tarosso","year":"2017","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.virol.2026.110788_bib54","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/s12879-017-2683-3","article-title":"Landscape review of current HIV \u2018kick and kill\u2019 cure research - some kicking, not enough killing","volume":"17","author":"Thorlund","year":"2017","journal-title":"BMC Infect. Dis."},{"issue":"5818","key":"10.1016\/j.virol.2026.110788_bib56","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1126\/science.1136319","article-title":"Suppression of microRNA-silencing pathway by HIV-1 during virus replication","volume":"315","author":"Triboulet","year":"2007","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.virol.2026.110788_bib57","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00417-23","article-title":"A truncated HIV tat demonstrates potent and specific latency reversal activity","volume":"67","author":"Van Gulck","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"issue":"22","key":"10.1016\/j.virol.2026.110788_bib58","doi-asserted-by":"crossref","first-page":"21154","DOI":"10.1021\/acsnano.5c06051","article-title":"Enhanced nano-vaccine utilizing biomineralized virus-like particles for efficient glioblastoma immunotherapy via the nose-to-brain delivery pathway","volume":"19","author":"Wang","year":"2025","journal-title":"ACS Nano"},{"issue":"17","key":"10.1016\/j.virol.2026.110788_bib59","doi-asserted-by":"crossref","first-page":"8514","DOI":"10.1128\/JVI.00736-11","article-title":"Phenotypic and immunologic comparison of clade B transmitted\/founder and chronic HIV-1 envelope glycoproteins","volume":"85","author":"Wilen","year":"2011","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2026.110788_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005709","article-title":"HIV-1 tat co-operates with IFN-Gamma and TNF-alpha to increase CXCL10 in human astrocytes","volume":"4","author":"Williams","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.virol.2026.110788_bib61","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/jvi.69.1.376-386.1995","article-title":"Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells","volume":"69","author":"Wiskerchen","year":"1995","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2026.110788_bib62","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12977-018-0413-6","article-title":"HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity","volume":"15","author":"Yu","year":"2018","journal-title":"Retrovirology"},{"key":"10.1016\/j.virol.2026.110788_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198258","article-title":"Conditional activation of an HIV-1 protease attenuated mutant by a leucine zipper dimerization motif","volume":"295","author":"Yu","year":"2021","journal-title":"Virus Res."},{"issue":"8","key":"10.1016\/j.virol.2026.110788_bib64","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/s41565-024-01679-1","article-title":"Virus-like structures for combination antigen protein mRNA vaccination","volume":"19","author":"Zhang","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.virol.2026.110788_bib65","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.phrs.2018.10.023","article-title":"T cell toxicity of HIV latency reversing agents","volume":"139","author":"Zhao","year":"2019","journal-title":"Pharmacol. Res."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:45:14Z","timestamp":1781790314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682226000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":63,"alternative-id":["S0042682226000036"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2026.110788","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective reactivation of latent HIV using CyclinT1-Tat-containing virus-like particles","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2026.110788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110788"}}